References
- World Health Organization. Last updated 2003. Adherence to long-term therapies. Evidence for action. Available at: http://www.who.int/chp/knowledge/publications/adherence_full_report.pdf [Last accessed 11 March 2015]
- Osterberg L, Blaschke T. Adherence to medication. N Engl J Med 2005;353:487-97
- Haynes RB, Dantes R. Patient compliance and the conduct and interpretation of therapeutic trials. Control Clin Trials 1987;8:12-19
- Chan JC, Gagliardino JJ, Baik SH, et al. IDMPS Investigators. Multifaceted determinants for achieving glycemic control: the International Diabetes Management Practice Study (IDMPS). Diabetes Care 2009;32:227-33
- Hoerger TJ, Segel JE, Gregg EW, Saaddine JB. Is glycemic control improving in U.S. adults? Diabetes Care 2008;31:81-6
- Liebl A, Mata M, Eschwège E; ODE-2 Advisory Board. Evaluation of risk factors for development of complications in type II diabetes in Europe. Diabetologia 2002;45:S23-8
- Stark Casagrande S, Fradkin JE, Saydah SH, et al. The prevalence of meeting A1C, blood pressure, and LDL goals among people with diabetes, 1988–2010. Diabetes Care 2013;36:2271-9
- Ho PM, Rumsfeld JS, Masoudi FA, et al. Effect of medication nonadherence on hospitalization and mortality among patients with diabetes mellitus. Arch Intern Med 2006;166:1836-41
- International Diabetes Federation. IDF Diabetes Atlas, 2014 (6th edition). Available at: http://www.idf.org/diabetesatlas/update-2014 [Last accessed 11 March 2015]
- Hirshberg B, Katz A. Cardiovascular outcome studies with novel antidiabetes agents: scientific and operational considerations. Diabetes Care 2013;36(Suppl 2):S253-8
- Petrie JR. The cardiovascular safety of incretin-based therapies: a review of the evidence. Cardiovasc Diabetol 2013;12:130
- Cramer JA, Roy A, Burrell A, et al. Medication compliance and persistence: terminology and definitions. Value Health 2008;11:44-7
- Raebel MA, Schmittdiel J, Karter AJ, et al. Standardizing terminology and definitions of medication adherence and persistence in research employing electronic databases. Med Care 2013;51(8 Suppl 3):S11-21
- Hwang YC, Kang M, Ahn CW, et al. Efficacy and safety of glimepiride/metformin sustained release once daily vs. glimepiride/metformin twice daily in patients with type 2 diabetes. Int J Clin Pract 2013;67:236-43
- Christensen AJ, Howren MB, Hillis SL, et al. Patient and physician beliefs about control over health: association of symmetrical beliefs with medication regimen adherence. J Gen Intern Med 2010;25:397-402
- Cohen HW, Shmukler C, Ullman R, et al. Measurements of medication adherence in diabetic patients with poorly controlled HbA(1c). Diabet Med 2010;27:210-16
- Hansen RA, Farley JF, Droege M, Maciejewski ML. A retrospective cohort study of economic outcomes and adherence to monotherapy with metformin, pioglitazone, or a sulfonylurea among patients with type 2 diabetes mellitus in the United States from 2003 to 2005. Clin Ther 2010;32:1308-19
- Sherman BW, Sekili A, Prakash ST, Rausch CA. Physician-specific variation in medication adherence among diabetes patients. Am J Manag Care 2011;17:729-36
- Shah NR, Hirsch AG, Zacker C, et al. Factors associated with first-fill adherence rates for diabetic medications: a cohort study. J Gen Intern Med 2009;24:233-7
- Currie CJ, Peyrot M, Morgan CL, et al. The impact of treatment noncompliance on mortality in people with type 2 diabetes. Diabetes Care 2012;35:1279-84
- Schoenthaler AM, Schwartz BS, Wood C, Stewart WF. Patient and physician factors associated with adherence to diabetes medications. Diabetes Educ 2012;38:397-408
- Rathore SS, Ketcham JD, Alexander GC, Epstein AJ. Influence of patient race on physician prescribing decisions: a randomized on line experiment. J Gen Intern Med 2009;24:1183-91
- Raebel MA, Ellis JL, Carroll NM, et al. Characteristics of patients with primary non-adherence to medications for hypertension, diabetes, and lipid disorders. J Gen Intern Med 2012;27:57-64
- Katon W, Russo J, Lin EHB, et al. Diabetes and poor disease control: is comorbid depression associated with poor medication adherence or lack of treatment intensification? Psychosom Med 2009;71:965-72
- Devine S, Vlahiotis A, Sundar H. A comparison of diabetes medication adherence and healthcare costs in patients using mail order pharmacy and retail pharmacy. J Med Econ 2010;13:203-11
- Buysman E, Connor C, Aagren M, et al. Adherence and persistence to a regimen of basal insulin in a pre-filled pen compared to vial/syringe in insulin-naïve patients with type 2 diabetes. Curr Med Res Opin 2011;27:1709-17
- Grabner M, Chu J, Raparla S, et al. Clinical and economic outcomes among patients with diabetes mellitus initiating insulin glargine pen versus vial. Postgrad Med 2013;125:204-13
- Lee LJ, Li Q, Reynolds MW, et al. Comparison of utilization, cost, adherence, and hypoglycemia in patients with type 2 diabetes initiating rapid-acting insulin analog with prefilled pen versus vial/syringe. J Med Econ 2011;14:75-86
- Xie L, Wei W, Pan C, et al. A real-world study of patients with type 2 diabetes initiating basal insulins via disposable pens. Adv Ther 2011;28:1000-11
- Donnelly LA, Morris AD, Pearson ER. Adherence in patients transferred from immediate release metformin to a sustained release formulation: a population-based study. Diabetes Obes Metab 2009;11:338-42
- van Bruggen R, Gorter K, Stolk RP, et al. Refill adherence and polypharmacy among patients with type 2 diabetes in general practice. Pharmacoepidemiol Drug Saf 2009;18:983-91
- Farmer A, Hardeman W, Hughes D, et al. An explanatory randomised controlled trial of a nurse-led, consultation-based intervention to support patients with adherence to taking glucose lowering medication for type 2 diabetes. BMC Fam Pract 2012;13:30
- Bogner HR, de Vries HF. Integrating type 2 diabetes mellitus and depression treatment among African Americans: a randomized controlled pilot trial. Diabetes Educ 2010;36:284-92
- Lin EH, Von Korff M, Ciechanowski P, et al. Treatment adjustment and medication adherence for complex patients with diabetes, heart disease and depression: a randomized controlled trial. Ann Fam Med 2012;10:6-14
- Rubak S, Sandbæk A, Lauritzen T, et al. Effect of ‘motivational interviewing’ on quality of care measures in screen detected type 2 diabetes patients: a one-year follow-up of an RCT, ADDITION. Scand J Prim Health 2011;29:92-8
- American Pharmacists Association. DOTx. MED: pharmacist-delivered interventions to improve care for patients with diabetes. J Am Pharm Assoc 2012;52:25-33
- Walker EA, Schmukler C, Ullman R, et al. Results of a successful telephonic intervention to improve diabetes control in urban adults: a randomized trial. Diabetes Care 2011;34:2-7
- Vervloet M, van Dijk L, Santen-Reestman J, et al. SMS reminders improve adherence to oral medication in type 2 diabetes patients who are real time electronically monitored. Int J Med Inform 2012;81:594-604
- Guldberg TL, Vedsted P, Kristensen JK, Lauritzen T. Improved quality of type 2 diabetes care following electronic feedback of treatment status to general practitioners: a cluster randomized controlled trial. Diabet Med 2011;28:325-32
- Bogner HR, Morales KH, de Vries HF, Cappola AR. Integrated management of type 2 diabetes mellitus and depression treatment to improve medication adherence: a randomized controlled trial. Ann Fam Med 2012;10:15-22
- Mehuys E, Van Bortel L, De Bolle L, et al. Effectiveness of a community pharmacist intervention in diabetes care: a randomized controlled trial. J Clin Pharm Ther 2011;36:602-13
- Branda ME, LeBlanc A, Shah ND, et al. Shared decision making for patients with type 2 diabetes: a randomized trial in primary care. BMC Health Serv Res 2013;13:301
- Prado-Aguilar CA, Martínez YV, Segovia-Bernal Y, et al. Performance of two questionnaires to measure treatment adherence in patients with type-2 diabetes. BMC Pub Health 2009;9:38
- van Onzenoort HAW, Menter F, Neef C, et al. Participation in a clinical trial enhanced adherence and persistence to treatment: a retrospective cohort study. Hypertension 2011;58:573-8
- Willens D, Cripps R, Wilson A, et al. Interdisciplinary team care for diabetic patients by primary care physicians, advanced practice nurses, and clinical pharmacists. Clin Diabetes 2011;29:60-8
- Satman I, Imamoglu S, Yilmaz C; ADMIRE Study Group. A patient-based study on the adherence of physicians to guidelines for the management of type 2 diabetes in Turkey. Diabetes Res Clin Pract 2012;98:75-82
- Hiscock R, Bauld L, Amos A, et al. Socioeconomic status and smoking: a review. Ann NY Acad Sci 2012;1248:107-23
- Mannan H, Stevenson C, Peeters A, et al. Framingham risk prediction equations for incidence of cardiovascular disease using detailed measures for smoking. Heart Int 2010;5:e11
- Seldenrijk A, Vogelzangs N, Batelaan NM, et al. Depression, anxiety and 6-year risk of cardiovascular disease. J Psychosom Res 2015;78:123-9
- Claxton AJ, Cramer J, Pierce C. A systematic review of the associations between dose regimens and medication compliance. Clin Ther 2001;23:1296-310
- Kardas P. The DIACOM study (effect of DosIng frequency of oral Antidiabetic agents on the COMpliance and biochemical control of type 2 diabetes). Diabetes Obes Metab 2005;7:722-8
- Nantz E, Lui H, Skljarvski V. Predictors of premature discontinuation of treatment in multiple disease states. Patient Pref Adh 2009;3:31-43
- Munro S, Lewin S, Swart S, Volmink J. A review of health behaviour theories: how useful are these for developing interventions to promote long-term medication adherence for TB and HIV/AIDS? BMC Pub Health 2007;7:104
- Hojat M, Louis D, Markham F, et al. Physicians’ empathy and clinical outcomes for diabetic patients. Acad Med 2011;86:359-64
- Atreja A, Bellam N, Levy S. Strategies to enhance patient adherence: making it simple. Med Gen Med 2005;7:4
- Viswanathan M, Golin C, Jones C, et al. Interventions to improve adherence to self-administered medications for chronic diseases in the United States: a systematic review. Ann Intern Med 2012;157:785-95
- Dale JR, Williams SM, Bowyer V. A systematic review of peer support on diabetes outcomes in adults. Diabet Med 2012;29:1361-77